These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1512796)

  • 1. Antagonism by suramin of the growth-inhibitory effect of hydroxytamoxifen and doxorubicin in human MCF-7 breast cancer cells.
    Berthois Y; Dong XF; Martin PM; Cvitkovic E
    J Natl Cancer Inst; 1992 Sep; 84(18):1438-9. PubMed ID: 1512796
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism between tamoxifen and doxorubicin in the MCF-7 human breast tumor cell line.
    Woods KE; Randolph JK; Gewirtz DA
    Biochem Pharmacol; 1994 Apr; 47(8):1449-52. PubMed ID: 8185652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.
    Ju YH; Doerge DR; Allred KF; Allred CD; Helferich WG
    Cancer Res; 2002 May; 62(9):2474-7. PubMed ID: 11980635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD; Sun JZ; Bi DS; Ma R
    Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V; Jensen EV; Knabbe C
    Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro.
    Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Peters HA; Klijn JG
    Br J Cancer; 1993 Feb; 67(2):232-6. PubMed ID: 8431356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
    Nomura Y; Tashiro H; Takaeko F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
    Butler WB; Fontana JA
    Cancer Res; 1992 Nov; 52(22):6164-7. PubMed ID: 1423259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7.
    Roos W; Oeze L; Löser R; Eppenberger U
    J Natl Cancer Inst; 1983 Jul; 71(1):55-9. PubMed ID: 6575210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A breast cancer clone selected by tamoxifen has increased growth rate and reduced sensitivity to doxorubicin.
    Maenpaa JU; Wurz GT; Baker WJ; Wiebe VJ; Emshoff VD; Koester SK; Seymour RC; Koehler RE; DeGregorio MW
    Oncol Res; 1993; 5(12):461-6. PubMed ID: 8086667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suramin inhibits the growth of human breast cancer cell lines. Studies on parental lines and corresponding sublines with acquired doxorubicin resistance with and without expression of P-glycoprotein.
    Lindman H; Taube A; Bergh JC
    Anticancer Res; 1994; 14(2A):363-6. PubMed ID: 7912491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.
    Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Dorssers LC; Berns EM; Klijn JG
    Int J Cancer; 1992 May; 51(3):439-44. PubMed ID: 1592534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies.
    Leonessa F; Jacobson M; Boyle B; Lippman J; McGarvey M; Clarke R
    Cancer Res; 1994 Jan; 54(2):441-7. PubMed ID: 7903910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens.
    Osborne CK; Kitten L; Arteaga CL
    J Clin Oncol; 1989 Jun; 7(6):710-7. PubMed ID: 2715802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
    Vickers PJ; Dickson RB; Shoemaker R; Cowan KH
    Mol Endocrinol; 1988 Oct; 2(10):886-92. PubMed ID: 3185565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro.
    Wilson ST; Blask DE; Lemus-Wilson AM
    J Clin Endocrinol Metab; 1992 Aug; 75(2):669-70. PubMed ID: 1639964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.